In South Africa, a high HIV and tuberculosis (TB) prevalent low-middle income country (LMIC) with a significant COVID-19 burden, antimicrobial usage for paediatric community-acquired infections (CAI) and healthcare-associated infections (HAI) are largely unknown.

This study aimed to provide antibiotic and antifungal point prevalence estimates for the treatment of CAI and HAI, or for prophylaxis, in the setting of academic hospitals in South Africa.

View the complete A point prevalence survey of paediatric antimicrobial use and healthcare-associated infections in three academic hospitals in South Africa - Policy Brief